enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
6.96
-0.24 (-3.33%)
Apr 28, 2026, 4:00 PM EDT - Market closed
enGene Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 |
| Net Income | -122.44 | -117.3 | -55.14 | -99.92 | -24.46 | -23.44 | Upgrade
|
| Depreciation & Amortization | 0.6 | 0.51 | 0.32 | 0.18 | 0.24 | 0.27 | Upgrade
|
| Other Amortization | - | - | - | 0.92 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.02 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.88 | -3.07 | -0.23 | - | - | - | Upgrade
|
| Stock-Based Compensation | 10.64 | 9.65 | 5.32 | 3.45 | 0.12 | 0.44 | Upgrade
|
| Other Operating Activities | 1.83 | 1.24 | 1.33 | 71.14 | 4.34 | 7.79 | Upgrade
|
| Change in Accounts Payable | -0.45 | 4.94 | 0.47 | 0.37 | -0.2 | 0.11 | Upgrade
|
| Change in Other Net Operating Assets | 11.03 | 5.39 | -2.39 | 0.12 | 2.23 | -1.44 | Upgrade
|
| Operating Cash Flow | -102.45 | -99.24 | -48.28 | -24.74 | -17.59 | -15.98 | Upgrade
|
| Capital Expenditures | -1.34 | -1.49 | -0.93 | -0.32 | -0.15 | -0.25 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
| Investment in Securities | -65.13 | -23.65 | -125.03 | - | - | - | Upgrade
|
| Investing Cash Flow | -66.47 | -25.14 | -125.95 | -0.32 | -0.15 | -0.25 | Upgrade
|
| Long-Term Debt Issued | - | - | 22.5 | 38 | 29.4 | 8.03 | Upgrade
|
| Long-Term Debt Repaid | - | -0.7 | -9.45 | -4.73 | -1.01 | -0.96 | Upgrade
|
| Net Debt Issued (Repaid) | 1.25 | -0.7 | 13.06 | 33.27 | 28.39 | 7.07 | Upgrade
|
| Issuance of Common Stock | 152 | 2.22 | 266.25 | 56.94 | 0.01 | 0.01 | Upgrade
|
| Other Financing Activities | -10.06 | - | -13.58 | -4.06 | -0.44 | -0.14 | Upgrade
|
| Financing Cash Flow | 143.18 | 1.52 | 265.72 | 86.15 | 27.97 | 22.53 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | 0 | 0 | -0.81 | 0.1 | Upgrade
|
| Net Cash Flow | -25.73 | -122.85 | 91.48 | 61.09 | 9.42 | 6.39 | Upgrade
|
| Free Cash Flow | -103.79 | -100.72 | -49.21 | -25.06 | -17.75 | -16.23 | Upgrade
|
| Free Cash Flow Per Share | -1.88 | -1.97 | -1.30 | -36.18 | -27.09 | -4.56 | Upgrade
|
| Cash Interest Paid | 2.3 | 2.29 | 1.93 | - | 0.62 | - | Upgrade
|
| Levered Free Cash Flow | -65.3 | -60.38 | -32.23 | -16.07 | -10.75 | - | Upgrade
|
| Unlevered Free Cash Flow | -63.45 | -58.51 | -30.48 | -13.89 | -9.86 | - | Upgrade
|
| Change in Working Capital | 9.8 | 9.74 | 0.1 | -0.52 | 2.17 | -1.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.